Menopause Tests

What menopause tests do
Menopause tests are urine tests that detect follicle-stimulating hormone (FSH) and are used to assess the onset of menopause. The company's published reading guidance for its FSH One Step Menopause Test Midstream states the outcomes in plain terms: a positive result, where the test line is the same colour as or darker than the control line, means FSH is above the normal level and the person may be in perimenopause; a negative result is a test line lighter than the control line or no test line; and a result with no control line is invalid. That wording is the company's own guidance, written in possible-outcome language, and this page keeps the same wording.
No menopause test on this site is described as a diagnostic or confirmatory device, and no result is described as a guarantee. The test is a qualitative urine test, and its result is one piece of information, not a medical conclusion.
What buyers usually ask
Menopause tests on this site are covered at category level. The company's category pages list an FSH menopause test midstream among its fertility testing products. No specification table for a menopause test is published in the company's own material, so this page carries no specification table.
Buyers sourcing menopause tests usually ask about format, packing configurations, shelf life and instruction languages. Those details vary by product and order; request written confirmation for the specific product and order.
Ordering notes
The company FAQ states that prices vary with supply and market factors, that international orders are subject to an ongoing minimum order requirement with no fixed figure published, that samples take about 7 days, and that mass production takes 20–30 days after deposit. Certificates are available upon request. Before payment, confirm availability, packing and current terms in writing.
FSH testing in context
FSH testing sits alongside LH and hCG testing in the fertility range, but it answers a different question. LH testing looks for a fertile window, hCG testing looks for pregnancy, and FSH testing looks at whether FSH is above the normal level, which may indicate perimenopause. Those three questions serve different buyers and different life stages, which is why a distributor stocking fertility products will usually stock all three rather than one alone.
The FSH midstream format is a self-contained test device rather than a bare strip, which changes its packing and its price point compared with strip tests. Format, packing and instruction languages for the FSH product should be confirmed in writing for the specific order, because no specification table for a menopause test is published on this site.
Reading guidance and its limits
The reading guidance for the company's FSH test is written in possible-outcome language: a test line the same colour as or darker than the control line means FSH is above the normal level and the person may be in perimenopause; a lighter test line or no test line is negative; and no control line is invalid. That 'may be' wording is deliberate and is preserved on this page, because a single FSH result is one piece of information, not a medical conclusion.
Questions about a result or about menopause belong with a healthcare professional. Trade buyers should make sure that the instructions supplied with their tests carry the same reading guidance in the languages of their markets.